Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia

被引:0
作者
Jakob Voelkl
Florian Lang
Kai-Uwe Eckardt
Kerstin Amann
Makoto Kuro-o
Andreas Pasch
Burkert Pieske
Ioana Alesutan
机构
[1] Johannes Kepler University Linz,Institute for Physiology and Pathophysiology
[2] Charité–Universitätsmedizin Berlin,Department of Internal Medicine and Cardiology
[3] DZHK (German Centre for Cardiovascular Research),Department of Nephrology and Medical Intensive Care
[4] Partner Site Berlin,Department of Physiology I
[5] Charité–Universitätsmedizin Berlin,Department of Nephropathology
[6] Eberhard-Karls University,Center for Molecular Medicine
[7] Universität Erlangen-Nürnberg,Department of Internal Medicine and Cardiology
[8] Jichi Medical University,undefined
[9] Calciscon AG,undefined
[10] Berlin Institute of Health (BIH),undefined
[11] German Heart Center Berlin (DHZB),undefined
来源
Cellular and Molecular Life Sciences | 2019年 / 76卷
关键词
Osteogenic signaling; Vascular smooth muscle cells; Vascular calcification; Phosphate; CKD;
D O I
暂无
中图分类号
学科分类号
摘要
Medial vascular calcification has emerged as a putative key factor contributing to the excessive cardiovascular mortality of patients with chronic kidney disease (CKD). Hyperphosphatemia is considered a decisive determinant of vascular calcification in CKD. A critical role in initiation and progression of vascular calcification during elevated phosphate conditions is attributed to vascular smooth muscle cells (VSMCs), which are able to change their phenotype into osteo-/chondroblasts-like cells. These transdifferentiated VSMCs actively promote calcification in the medial layer of the arteries by producing a local pro-calcifying environment as well as nidus sites for precipitation of calcium and phosphate and growth of calcium phosphate crystals. Elevated extracellular phosphate induces osteo-/chondrogenic transdifferentiation of VSMCs through complex intracellular signaling pathways, which are still incompletely understood. The present review addresses critical intracellular pathways controlling osteo-/chondrogenic transdifferentiation of VSMCs and, thus, vascular calcification during hyperphosphatemia. Elucidating these pathways holds a significant promise to open novel therapeutic opportunities counteracting the progression of vascular calcification in CKD.
引用
收藏
页码:2077 / 2091
页数:14
相关论文
共 270 条
[1]  
Paloian NJ(2014)A current understanding of vascular calcification in CKD Am J Physiol Renal Physiol 307 F891-F900
[2]  
Giachelli CM(2011)Arterial calcification in chronic kidney disease: key roles for calcium and phosphate Circ Res 109 697-711
[3]  
Shanahan CM(2016)Vascular calcification in chronic kidney disease: an update Nephrol Dial Transplant 31 31-39
[4]  
Schlieper G(2004)Osteogenic regulation of vascular calcification: an early perspective Am J Physiol Endocrinol Metab 286 E686-E696
[5]  
Vattikuti R(1994)Calcification of the human thoracic aorta during aging Calcif Tissue Int 54 268-273
[6]  
Towler DA(2014)Medial vascular calcification revisited: review and perspectives Eur Heart J 35 1515-1525
[7]  
Elliott RJ(2008)Vascular calcification: pathobiology of a multifaceted disease Circulation 117 2938-2948
[8]  
McGrath LT(2017)Inherited arterial calcification syndromes: etiologies and treatment concepts Curr Osteoporos Rep 15 255-270
[9]  
Lanzer P(2011)Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel Circ Res 109 578-592
[10]  
Demer LL(2006)Vascular calcification: pathobiological mechanisms and clinical implications Circ Res 99 1044-1059